Mereo BioPharma Group PLC ADR (MREO) earnings · rev $500.0K
These earnings events as JSON? API free 100/dayMereo BioPharma Group PLC ADR (MREO) is a biotechnology company listed on US.
This MREO earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported MREO revenue for 2025-12-31 was $500.0K. Net income was -$41.9M. MREO currently screens at market cap $48.7M.
When the next MREO 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
Period-over-period revenue change is not in cache for MREO. We will not invent a beat or miss.
Not investment advice. Full MREO research stays on the stock page; the tape stays on the quote page.
MREO earnings FAQ
What are MREO's latest revenue and net income?
Latest cached Mereo BioPharma Group PLC ADR (MREO) revenue for Dec 31, 2025 was $500.0K. Net income was -$41.9M. Statements: https://lician.com/financials/mreo
What is MREO's latest diluted EPS?
Latest cached Mereo BioPharma Group PLC ADR (MREO) diluted EPS for Dec 31, 2025 was -$0.05.
What period does the latest MREO earnings print cover?
The latest cached Mereo BioPharma Group PLC ADR (MREO) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
Where are MREO earnings listed?
Cached earnings facts for Mereo BioPharma Group PLC ADR (MREO) are listed at https://lician.com/earnings/mreo. Statements: https://lician.com/financials/mreo
Not investment advice.